|
Besides Teranetics’ team, which possesses extensive experience in high-performance mixed-signal circuits as well as in digital communications technologies, Teranetics also has the financial backing of a strong consortium of venture investor partners with a proven track record of successful investments in the semiconductor and data networking sectors.
Teranetics Investment Partners include:
 Columbia Capital is a venture capital firm specializing in the communications and information technology industries. Columbia Capital has an experienced investment team with diverse industry backgrounds in entrepreneurial ventures, management, finance, regulation and engineering. The team has managed investments in approximately 100 companies in the communications and information technology sectors, ranging from small, early-stage investments to multibillion-dollar public companies. Columbia Capital's most recent private equity fund of $520 million raised in 2005 brings the total dollars under management to $1.8 billion. Columbia Capital targets companies that have significant potential to benefit from major industry trends, grow substantially over a period of three to eight years and remain viable and profitable enterprises over the long term. Their portfolio includes: Altiga, Ocular, Torrent, and Vallent.
Global Catalyst Partners seeks out visionary entrepreneurial leaders with innovative, competitive information technologies. Focusing on seed and early stage investments, the partners take an intensive, hands-on investment approach to turn compelling ideas into successful companies. Drawing on a worldwide network of expertise in information technologies, marketing, manufacturing, legal issues, and financing, GCP brings companies the critical resources needed to thrive during high speed growth cycles. Typically acting as a lead investor, GCP works closely with other leading venture capital funds in the US, Israel and Asia.
Granite Global Ventures (GGV) leads expansion-stage venture capital investments in the United States and Asia, combining global vision with local insight. Since its inception, GGV has pursued a dual focus on the U.S. and China. We are one of the first VC firms to fund start-ups in China and among the first to actively introduce U.S. companies to new markets in the region. GGV works closely with entrepreneurs – providing the experience, global perspective, and extensive networks of relationships that accelerate success.
Portview Communications Partners is a specialized international venture capital fund investing in next-generation communications and related technologies, systems and applications. Portview backs companies in Israel and the U.S. with the potential for global leadership in their fields. Portview brings to its portfolio companies a solid understanding of the market; international experience; strong relationships; company-building expertise; and hands-on assistance. Their portfolio includes: Ceragon, Floware, Teknovus, and TTI.
U.S. Venture Partners (USVP) invests primarily in early stage technology companies, particularly those involved in datacomm, Internet and intranet hardware and software, networking products, semiconductors, enterprise and client productivity software, and electronic design automation software. Their portfolio includes: StrataCom, MMC Networks, NeoMagic, IOMEGA, Sun Microsystems, Xylan, Checkpoint Software, and Crescendo Communications.
Venrock Associates Venrock is a premier venture capital firm with offices in Menlo Park, New York, Cambridge, MA, and Israel. Originally established as the venture capital arm of the Rockefeller family, Venrock continues a seven-decade tradition of funding entrepreneurs and establishing successful, enduring companies. Having invested $1.8 billion in 400 companies resulting in over 120 IPOs over the past 38 years, Venrock’s investment returns place it among the top tier venture capital firms that have achieved consistently superior performance. With a primary focus on information technology, healthcare, and energy, portfolio companies have included Intel, Apple Computer, StrataCom, Check Point Software, and DoubleClick; Sirna Therapeutics, Centocor, Idec Pharmaceuticals, Sugen, Millennium Pharmaceuticals, and Illumina. For more information, please visit Venrock’s website at www.venrock.com
Teranetics has also received investment from Hook Partners and PACGEN Ventures. |
|
